Legend Biotech LEGN
NASDAQ LEGN
$21.52 -0.23 (-1.06%)
As of: Sep 4, 2026 · 3:59 PM EDT

Legend Biotech (LEGN) Gains from Sales and Divestitures (2021 - 2025)

Analysis

Legend Biotech (LEGN) Gains from Sales and Divestitures (2021 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Legend Biotech 3.97 Bn 3.00 Bn 251.50 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 197,000.00
Mar 31, 2025 53,000.00
Mar 31, 2024 2,000.00
Dec 31, 2023 3,000.00
Sep 30, 2023 82,000.00
Jun 30, 2023 66,000.00
Mar 31, 2023 75,000.00
Dec 31, 2022 473,000.00
Sep 30, 2022 -11,000.00
Jun 30, 2022 -1,000.00
Mar 31, 2022 20,000.00
Mar 31, 2021 54,000.00